Monte Rosa Therapeutics, Inc. (GLUE) Free cash flow 2020–2025
Monte Rosa Therapeutics, Inc. (GLUE) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$27.5MFY2025 · since FY2020: -$26.4M → -$27.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$27.5M | -172.3% |
| FY2024 | $38.0M | +160.5% |
| FY2023 | -$62.8M | +40.4% |
| FY2022 | -$105.4M | -52.5% |
| FY2021 | -$69.1M | -161.3% |
| FY2020 | -$26.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice